Department of Obstetrics and Gynecology, Second Xiangya Hospital of Central South University, Hunan, China.
BJOG. 2009 Nov;116(12):1633-9. doi: 10.1111/j.1471-0528.2009.02347.x. Epub 2009 Sep 14.
To analyse the phenotypic spectrum of polycystic ovary syndrome (PCOS) and determine the association between metabolic, hormonal and new ultrasonographic criteria.
Clinical cross-sectional study.
University teaching hospital.
A total of 804 Chinese women, among whom 719 cases were diagnosed as PCOS based on the 2003 Rotterdam criteria. Eighty-five women with regular menstrual cycles and without hyperandrogenism were recruited as controls.
PCOS patients were divided into four subgroups: (i) oligo- and/or anovulation (O), hyperandrogenism (H), and polycystic ovary morphology (P); (ii) O + H; (iii) H + P; and (iv) O + P.
Clinical history, ultrasonographic (ovarian follicle number and volume), hormonal and metabolic parameters.
The composition of the two new phenotypes created by the European Society for Human Reproduction and Embryology/The American Society for Reproductive Medicine (ESHRE/ASRM) 2003 was 65.6% (O + P and H + P). BMI and F-G scores were highest in the O + H + P group and lowest in O + P and controls. Serum testosterone concentrations and insulin resistance were highest in cases with O + H + P and O + H, intermediate in cases with H + P, and lowest in cases with O + P and controls. The prevalence of metabolic syndrome in the five groups was 28.5% (O + H + P), 25.5% (O + H), 8.3% (H + P), 7.2% (O + P) and 3.5% (controls), respectively.
Nonclassic phenotypes for PCOS (O + P, H + P and O + H + P) were more frequent than the classic phenotype (O + H). The nonhyperandrogenic PCOS phenotype (O + P), one of the new phenotypes created by the Rotterdam criteria, may represent a form of PCOS associated with milder metabolic profile compared with the other phenotypes.
分析多囊卵巢综合征(PCOS)的表型谱,并确定代谢、激素和新超声标准之间的关联。
临床横断面研究。
大学教学医院。
共纳入 804 例中国女性,其中 719 例符合 2003 年鹿特丹标准诊断为 PCOS。85 例月经周期规律且无高雄激素血症的妇女被招募为对照组。
将 PCOS 患者分为四组:(i)少卵和/或无排卵(O)、高雄激素血症(H)和多囊卵巢形态(P);(ii)O+H;(iii)H+P;和(iv)O+P。
临床病史、超声(卵巢卵泡数和体积)、激素和代谢参数。
欧洲人类生殖与胚胎学会/美国生殖医学学会(ESHRE/ASRM)2003 年提出的两种新表型的构成比为 65.6%(O+P 和 H+P)。O+H+P 组的 BMI 和 F-G 评分最高,O+P 和对照组最低。O+H+P 和 O+H 组的血清睾酮浓度和胰岛素抵抗最高,H+P 组次之,O+P 和对照组最低。五组代谢综合征的患病率分别为 28.5%(O+H+P)、25.5%(O+H)、8.3%(H+P)、7.2%(O+P)和 3.5%(对照组)。
非经典表型 PCOS(O+P、H+P 和 O+H+P)比经典表型(O+H)更常见。新的 Rotterdam 标准之一的非高雄激素血症 PCOS 表型(O+P)与其他表型相比,可能代表一种与更轻微代谢特征相关的 PCOS 形式。